Cosmos Health Inc.

Cosmos Health Inc.

2.49
USD
-0.75
(-23.15%)
-2.60EPS
14.90MMarket Cap
Nov 17Next Earn

Total Valuation

USD

As of June 30, 2026, Cosmos Health Inc. carries a market capitalization of 14.90M, placing it among publicly traded companies globally. Its enterprise value stands at 29.04M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap14.90M
Enterprise Value29.04M

Important Dates

Cosmos Health Inc.'s next confirmed earnings release is scheduled for November 17, 2026.

Earnings Date11/17/2026

Share Statistics

As of June 30, 2026, Cosmos Health Inc. has 4.03M shares outstanding.

Shares Outstanding4.03M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 0.47, and the price-to-book ratio stands at 0.72.

PS Ratio0.47
PB Ratio0.72
P/TBV Ratio1.09
P/FCF Ratio-3.49
P/OCF Ratio-3.53

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 0.39 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 29.04M versus a market cap of 14.90M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.39

Financial Position

As of June 30, 2026, Cosmos Health Inc. maintains a current ratio of 1.05, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 77.27, indicating elevated leverage, while an interest coverage ratio of -4.58 demonstrates limited ability to service its debt obligations.

Current Ratio1.05
Quick Ratio0.68
Debt / Equity77.27
Debt / EBITDA-0.94
Interest Coverage-4.58

Financial Efficiency

USD

Over the twelve months ended June 30, 2026, Cosmos Health Inc. posted a negative return on equity (ROE) of -104.00, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -39.56, reflecting losses generated across the asset base. The company generates approximately 462,243.59 in revenue per employee across its workforce of 159.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 13.74 indicates how many times Cosmos Health Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-104.00
Return on Assets (ROA)-39.56
Revenue Per Employee462,243.59
Employee Count159.50
Inventory Turnover13.74

Stock Price Statistics

USD

As of the close on November 16, 2026, Cosmos Health Inc.'s stock has declined approximately 82.76% over the past 52 weeks. The 50-day moving average sits at 6.08, while the 200-day moving average is 5.94.

52-Week Price Change-82.76%
50-Day Moving Average6.08
200-Day Moving Average5.94

Income Statement

USD

Over the twelve months ended June 30, 2026, Cosmos Health Inc. generated 73.73M in revenue and converted that into -24.39M in net income, yielding earnings per share of -2.60. EBITDA reached -16.94M, while operating income came in at -18.17M.

Revenue73.73M
Gross Profit7.57M
Operating Income-18.17M
Pretax Income-24.39M
Net Income-24.39M
EBITDA-16.94M
EBIT-18.33M
Earnings Per Share (EPS)-2.60

Balance Sheet

USD

As of June 30, 2026, Cosmos Health Inc. holds 1.84M in cash and equivalents against 15.98M in total debt, resulting in a net debt position of 13.54M. Total book value stands at 20.67M, with working capital of 1.83M providing operational flexibility.

Cash & Cash Equivalents1.84M
Total Debt15.98M
Net Debt13.54M
Equity (Book Value)20.67M
Book Value Per Share5.13
Working Capital1.83M

Cash Flow

USD

Cosmos Health Inc. produced -9.84M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -95,488.00 in capital expenditures, free cash flow totaled -9.93M - equivalent to -1.06 per share.

Operating Cash Flow-9.84M
Capital Expenditures-95,488.00
Free Cash Flow-9.93M
FCF Per Share-1.06

Margins

Over the twelve months ended June 30, 2026, Cosmos Health Inc. posted a gross margin of 10.27, reflecting its pricing power and cost economics. The operating margin of -24.65 and net profit margin of -33.08 provide insight into operational efficiency.

Gross Margin10.27
Operating Margin-24.65
Pretax Margin-33.08
Profit Margin-33.08
EBITDA Margin-22.98

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -28.62: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -94.14, meaning Cosmos Health Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-94.14
FCF Yield-28.62

Stock Splits

Cosmos Health Inc.'s most recent stock split took place on November 13, 2026 with a 20:1 split ratio.

Last Split Date11/13/2026
Split Ratio20:1

Scores

As of June 30, 2026, Cosmos Health Inc. has an Altman Z-Score of -3.14, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-3.14